CDT Equity (CDT) Enterprise Value (QoQ) (2022 - 2026)
CDT Equity (CDT) Enterprise Value (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | CDT Equity | 1.59 Mn | 1.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -670.10% |
| Mar 31, 2026 | 93.57% |
| Dec 31, 2025 | 60.29% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | -56.43% |
| Mar 31, 2025 | -255.00% |
| Dec 31, 2024 | -745.07% |
| Sep 30, 2024 | 67.58% |
| Jun 30, 2024 | 88.12% |
| Mar 31, 2024 | 56.39% |
| Dec 31, 2023 | 51.09% |
| Sep 30, 2023 | -3,012.03% |
| Jun 30, 2023 | -206.56% |
| Mar 31, 2023 | 73.80% |
| Dec 31, 2022 | 52.51% |
| Sep 30, 2022 | 13.09% |
| Jun 30, 2022 | 13.16% |
| Mar 31, 2022 | -1,886.62% |